Sanat’s manufacturing unit in Sikandrabad undergoes successful USFDA inspection

The USFDA team thoroughly reviewed Sanat products’s herbal extract manufacturing, quality control, and quality assurance procedures during an inspection that was carried out during December 2017


New Delhi: The capital-based Sanat Products has successfully completed USFDA site inspection for their herbal extract manufacturing facility based out of Sikandrabad, Uttar Pradesh, India.

Established in the year 1984, Sanat Products is engaged in the manufacturing and marketing of pharmaceutical, nutraceuticals, cosmeceuticals and herbal extracts.

The inspection was carried out in December 2017 in which the USFDA thoroughly reviewed Sanat’s herbal extract manufacturing, quality control and quality assurance procedures. The inspection confirmed the site to be compliant with the principles and guidelines of USFDA’s Quality System/Current Good Manufacturing Practices and no Form 483 observations were issued.

Mr Amit Sharma ( Business Head and Director), Sanat Products commented: “The success of the recent USFDA inspection is a testament to the quality of our processes and ingredients we offer. We are delighted with the outcomes and look forward to increasing our sales into the US and helping our valued customers gain further approvals for finished products.